Solvonis Therapeutics's market cap is currently £19.87M. The company's EPS TTM is p0; its P/E ratio is ―; Solvonis Therapeutics is scheduled to report earnings on September 30, 2025, and the estimated EPS forecast is p―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23
Dec 22
Dec 21
Dec 20
Dec 19
Currency in GBP
Solvonis Therapeutics Earnings and Revenue History
